FDA’s LDT Proposal Raises Questions About Clinical Validity
Debate is underway on whether current CLIA review of LDTs properly assesses a test’s likelihood to detect diseases.
Subscribe to Clinical Diagnostics Insider to view
Start a Free Trial for immediate access to this article